Shao H - Search Results

1

Implementing Lifestyle Change Interventions to Prevent Type 2 Diabetes in US Medicaid Programs: Cost Effectiveness, and Cost, Health, and Health Equity Impact.

Laxy M, Zhang P, Ng BP, Shao H, Ali MK, Albright A, Gregg EW. Laxy M, et al. Among authors: shao h. Appl Health Econ Health Policy. 2020 Oct;18(5):713-726. doi: 10.1007/s40258-020-00565-w. Appl Health Econ Health Policy. 2020. PMID: 32607728 Free PMC article.

2

Cost-effectiveness analysis of exenatide twice daily (BID) vs insulin glargine once daily (QD) as add-on therapy in Chinese patients with Type 2 diabetes mellitus inadequately controlled by oral therapies.

Deng J, Gu S, Shao H, Dong H, Zou D, Shi L. Deng J, et al. Among authors: shao h. J Med Econ. 2015;18(11):974-89. doi: 10.3111/13696998.2015.1067622. Epub 2015 Aug 20. J Med Econ. 2015. PMID: 26134916 Free article.

3

Cost-effectiveness analysis of dapagliflozin versus glimepiride as monotherapy in a Chinese population with type 2 diabetes mellitus.

Shao H, Zhai S, Zou D, Mir MU, Zawadzki NK, Shi Q, Liu S, Shi L. Shao H, et al. Curr Med Res Opin. 2017 Feb;33(2):359-369. doi: 10.1080/03007995.2016.1257978. Epub 2016 Nov 23. Curr Med Res Opin. 2017. PMID: 27817216

4

Influence of Diabetes Complications on HbA_1c Treatment Goals Among Older U.S. Adults: A Cost-effectiveness Analysis.

Shao H, Lin J, Zhuo X, Rolka DB, Gregg EW, Zhang P. Shao H, et al. Diabetes Care. 2019 Nov;42(11):2136-2142. doi: 10.2337/dc19-0381. Epub 2019 Sep 17. Diabetes Care. 2019. PMID: 31530661

5

Selecting the optimal risk threshold of diabetes risk scores to identify high-risk individuals for diabetes prevention: a cost-effectiveness analysis.

Mühlenbruch K, Zhuo X, Bardenheier B, Shao H, Laxy M, Icks A, Zhang P, Gregg EW, Schulze MB. Mühlenbruch K, et al. Among authors: shao h. Acta Diabetol. 2020 Apr;57(4):447-454. doi: 10.1007/s00592-019-01451-1. Epub 2019 Nov 19. Acta Diabetol. 2020. PMID: 31745647 Free PMC article.

6

A Systematic Review of Cost-Effectiveness of Sodium-Glucose Cotransporter Inhibitors for Type 2 Diabetes.

Yoshida Y, Cheng X, Shao H, Fonseca VA, Shi L. Yoshida Y, et al. Among authors: shao h. Curr Diab Rep. 2020 Mar 12;20(4):12. doi: 10.1007/s11892-020-1292-5. Curr Diab Rep. 2020. PMID: 32166504

7

Factors Contributing to the Rising National Cost of Glucose-Lowering Medicines for Diabetes During 2005-2007 and 2015-2017.

Zhou X, Shrestha SS, Shao H, Zhang P. Zhou X, et al. Among authors: shao h. Diabetes Care. 2020 Oct;43(10):2396-2402. doi: 10.2337/dc19-2273. Epub 2020 Jul 31. Diabetes Care. 2020. PMID: 32737138 Free PMC article.

8

Evaluating the Ability of Economic Models of Diabetes to Simulate New Cardiovascular Outcomes Trials: A Report on the Ninth Mount Hood Diabetes Challenge.

Si L, Willis MS, Asseburg C, Nilsson A, Tew M, Clarke PM, Lamotte M, Ramos M, Shao H, Shi L, Zhang P, McEwan P, Ye W, Herman WH, Kuo S, Isaman DJ, Schramm W, Sailer F, Brennan A, Pollard D, Smolen HJ, Leal J, Gray A, Patel R, Feenstra T, Palmer AJ. Si L, et al. Among authors: shao h. Value Health. 2020 Sep;23(9):1163-1170. doi: 10.1016/j.jval.2020.04.1832. Epub 2020 Aug 6. Value Health. 2020. PMID: 32940234 Free article.

9

Estimating costs of diabetes complications in people <65 years in the U.S. using panel data.

Yang W, Cintina I, Hoerger T, Neuwahl SJ, Shao H, Laxy M, Zhang P. Yang W, et al. Among authors: shao h. J Diabetes Complications. 2020 Dec;34(12):107735. doi: 10.1016/j.jdiacomp.2020.107735. Epub 2020 Sep 6. J Diabetes Complications. 2020. PMID: 32962890

10

The Lancet Commission on diabetes: using data to transform diabetes care and patient lives.

Chan JCN, Lim LL, Wareham NJ, Shaw JE, Orchard TJ, Zhang P, Lau ESH, Eliasson B, Kong APS, Ezzati M, Aguilar-Salinas CA, McGill M, Levitt NS, Ning G, So WY, Adams J, Bracco P, Forouhi NG, Gregory GA, Guo J, Hua X, Klatman EL, Magliano DJ, Ng BP, Ogilvie D, Panter J, Pavkov M, Shao H, Unwin N, White M, Wou C, Ma RCW, Schmidt MI, Ramachandran A, Seino Y, Bennett PH, Oldenburg B, Gagliardino JJ, Luk AOY, Clarke PM, Ogle GD, Davies MJ, Holman RR, Gregg EW. Chan JCN, et al. Among authors: shao h. Lancet. 2021 Dec 19;396(10267):2019-2082. doi: 10.1016/S0140-6736(20)32374-6. Epub 2020 Nov 12. Lancet. 2021. PMID: 33189186 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,390 results

Search Page